| Dr Justin Mackenzie Vining, MD | |
|
2418 E Plaza Dr, Tallahassee, FL 32308-5301 | |
| (850) 629-4861 | |
| (850) 629-4859 |
| Full Name | Dr Justin Mackenzie Vining |
|---|---|
| Gender | Male |
| Speciality | Pediatrics - Pediatric Cardiology |
| Location | 2418 E Plaza Dr, Tallahassee, Florida |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184886822 | NPI | - | NPPES |
| 066664 | Other | GA LICENSES |
| Entity Name | Phoebe Putney Memorial Hospital, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992789721 PECOS PAC ID: 4486559549 Enrollment ID: O20031203000397 |
News Archive
RedHill Biopharma Ltd., a specialty pharma company that is a leader in the development of novel oral therapies for COVID-19, today announced that all treatment and follow-up has now been completed in the 475-patient global Phase 2/3 study with opaganib (ABC294640) in patients hospitalized with severe COVID-19 pneumonia (NCT04467840). Top-line results are expected in the coming weeks.
More than 1,000 medications, with acetaminophen being the most common, have been associated with drug-induced liver injury.
The insurers have assumed that everyone would be required to have coverage by March 31. If the enrollment period is extended for a significant period, the sickest people are most likely to sign up early and the healthiest will likely hang back, driving up the costs ... there is no need for despair. In the long run, the technical problems can and will be fixed and most Americans will be better off.
News outlets report on various provisions of the health law and their impact on the marketplace and access to care.
› Verified 7 days ago
| Entity Name | Au Medical Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841230620 PECOS PAC ID: 9931013513 Enrollment ID: O20040107000188 |
News Archive
RedHill Biopharma Ltd., a specialty pharma company that is a leader in the development of novel oral therapies for COVID-19, today announced that all treatment and follow-up has now been completed in the 475-patient global Phase 2/3 study with opaganib (ABC294640) in patients hospitalized with severe COVID-19 pneumonia (NCT04467840). Top-line results are expected in the coming weeks.
More than 1,000 medications, with acetaminophen being the most common, have been associated with drug-induced liver injury.
The insurers have assumed that everyone would be required to have coverage by March 31. If the enrollment period is extended for a significant period, the sickest people are most likely to sign up early and the healthiest will likely hang back, driving up the costs ... there is no need for despair. In the long run, the technical problems can and will be fixed and most Americans will be better off.
News outlets report on various provisions of the health law and their impact on the marketplace and access to care.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Justin Mackenzie Vining, MD Po Box 44047, Jacksonville, FL 32231-4047 Ph: (904) 376-4083 | Dr Justin Mackenzie Vining, MD 2418 E Plaza Dr, Tallahassee, FL 32308-5301 Ph: (850) 629-4861 |
News Archive
RedHill Biopharma Ltd., a specialty pharma company that is a leader in the development of novel oral therapies for COVID-19, today announced that all treatment and follow-up has now been completed in the 475-patient global Phase 2/3 study with opaganib (ABC294640) in patients hospitalized with severe COVID-19 pneumonia (NCT04467840). Top-line results are expected in the coming weeks.
More than 1,000 medications, with acetaminophen being the most common, have been associated with drug-induced liver injury.
The insurers have assumed that everyone would be required to have coverage by March 31. If the enrollment period is extended for a significant period, the sickest people are most likely to sign up early and the healthiest will likely hang back, driving up the costs ... there is no need for despair. In the long run, the technical problems can and will be fixed and most Americans will be better off.
News outlets report on various provisions of the health law and their impact on the marketplace and access to care.
› Verified 7 days ago
Dr. Laura Ongiri Howard, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1300 Miccosukee Rd, Tallahassee, FL 32308 Phone: 850-431-1155 | |
Charles Long, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1205 Marion Ave, Tallahassee, FL 32303 Phone: 850-681-3887 Fax: 850-681-0569 | |
Robert O. Middlemas, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1301 Hodges Dr, Tallahassee, FL 32308 Phone: 850-431-5714 Fax: 850-431-6403 | |
Dr. Maci Mcdermott, M.D, Pediatrics Medicare: Medicare Enrolled Practice Location: 3606 Maclay Blvd, Ste 102, Tallahassee, FL 32312 Phone: 850-877-1162 Fax: 850-671-5009 | |
Dr. Lionel Anthony Henry, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1638 N Plaza Dr, Tallahassee, FL 32308 Phone: 850-878-5147 Fax: 850-942-9844 | |
Dr. Nancy M. Wright, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1804 Miccosukee Commons Dr, Suite 210, Tallahassee, FL 32308 Phone: 850-656-3361 Fax: 850-656-6870 | |
Ms. Meena A Shahane, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 960 Learning Way, Tallahassee, FL 32306 Phone: 850-644-1802 Fax: 850-644-4251 |